IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.67▼ 0.02% USD/MXN18.61▲ 0.52% USD/CLP994.16▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN3.41▲ 0.17% USD/ARS1,544▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ7.64— 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES911.74▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69— 0.00% USD/TTD6.75— 0.00% EUR/BRL6.25▼ 0.04% BRENT 96.30 ▲ 0.48% WTI 89.16 ▲ 0.68% IRON ORE 161.91 — — COPPER 6.02 ▼ 1.06% GOLD 3,855 ▼ 0.81% SILVER 47.36 ▼ 3.41% SOY 1,227 ▼ 1.31% CORN 444.00 ▼ 0.34% WHEAT 587.00 ▼ 1.05% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00% IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.67 ▼ 0.02% USD/MXN 18.60 ▲ 0.49% USD/CLP 994.16 ▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN 3.41 ▲ 0.16% USD/ARS 1,544 ▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 ▲ 3.24% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES 911.74 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.75% USD/TTD 6.75 ▲ 2.58% EUR/BRL 6.25 ▼ 0.04% BRENT 96.30 ▲ 0.48% WTI 89.16 ▲ 0.68% IRON ORE 161.91 — — COPPER 6.02 ▼ 1.06% GOLD 3,855 ▼ 0.81% SILVER 47.36 ▼ 3.41% SOY 1,227 ▼ 1.31% CORN 444.00 ▼ 0.34% WHEAT 587.00 ▼ 1.05% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00%
since 2009
Monday, November 16, 2026

Fleury Expands Regional Reach with R$39.5 Million Hemolab Acquisition

By · · 2 min read

Fleury, one of Brazil’s leading diagnostic medicine groups, has agreed to purchase Hemolab Medicina Laboratorial for R$39.5 ($7) million, according to an official company statement.

Hemolab operates 15 clinical analysis and pathology units across nine cities in Minas Gerais. Last year, Hemolab reported R$31 million in revenue, reflecting its established presence in the region.

This acquisition marks another step in Fleury’s strategy to expand its footprint through targeted purchases. The company has pursued similar moves in recent years, including the acquisition of Méthodos in southern Minas Gerais.

Free daily brief — no card needed
Get every Market Reports story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

It also combined with Hermes Pardini, adding more than 500 service units and raising Fleury’s combined annual revenue to R$7.1 billion. The group now operates 108 units in Minas Gerais alone.

Fleury paid a multiple of 4.7 times Hemolab’s earnings before interest, taxes, depreciation, and amortization (EBITDA), dropping to 3.4 times when considering expected synergies.

Fleury Expands Regional Reach with R$39.5 Million Hemolab Acquisition
Fleury Expands Regional Reach with R$39.5 Million Hemolab Acquisition.
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

These figures show that Fleury expects to improve efficiency and profitability by integrating Hemolab’s operations. The company’s CEO, Jeane Tsutsui, stated that the acquisition aligns with Fleury’s financial strength and strategic criteria, including price, cultural fit, and growth potential.

Fleury’s expansion reflects a broader trend in Brazil’s healthcare sector, where large groups consolidate smaller regional players to gain scale and efficiency. This approach allows companies to lower costs, improve service quality, and expand their customer base.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Exxon gets Guyana approval for a gas project”

In the case of Fleury, the company’s recent acquisitions have focused on regions with growing demand for diagnostics and a high proportion of residents with health insurance.

Hemolab, with over 30 years of experience, brings local expertise and a reputation for quality service. Fleury’s integration of Hemolab could mean broader access to advanced diagnostics for patients in Minas Gerais. The deal remains subject to regulatory approval.

Fleury’s acquisition strategy has not increased its debt levels, as the company maintains a leverage rate of about 1.2 times net debt. The group continues to invest in technology and organic growth, aiming to strengthen its position as a leading healthcare provider in Brazil’s competitive diagnostics market.

Live Company IntelligenceFleury S.A. — the full investor dossierCompany overview and the latest Rio Times coverage.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Read More from The Rio Times

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.